Home/Filings/4/0001846253-25-000013
4//SEC Filing

FOEHR MATTHEW W 4

Accession 0001846253-25-000013

CIK 0001846253other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 8:51 PM ET

Size

19.3 KB

Accession

0001846253-25-000013

Insider Transaction Report

Form 4
Period: 2025-02-15
FOEHR MATTHEW W
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-15+26,5493,776,188 total
  • Exercise/Conversion

    Common Stock

    2025-02-16+36,4583,812,646 total
  • Sale

    Common Stock

    2025-02-18$3.68/sh13,964$51,3883,798,682 total
  • Sale

    Common Stock

    2025-02-19$3.67/sh19,522$71,6463,779,160 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-1526,549208,846 total
    Common Stock (26,549 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-1636,458172,388 total
    Common Stock (36,458 underlying)
  • Award

    Restricted Stock Units

    2025-02-18+175,000347,388 total
    Common Stock (175,000 underlying)
  • Award

    Stock Option (right to buy)

    2025-02-18+1,050,0001,050,000 total
    Exercise: $3.66Exp: 2035-02-18Common Stock (1,050,000 underlying)
Footnotes (8)
  • [F1]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 15, 2023.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025.
  • [F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.83. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  • [F7]The RSU grant vests in three substantially equal annual installments beginning on February 18, 2026.
  • [F8]The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Issuer

OmniAb, Inc.

CIK 0001846253

Entity typeother

Related Parties

1
  • filerCIK 0001237556

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:51 PM ET
Size
19.3 KB